Long-Term Outcomes in Patients With Advanced NSCLC Who Completed 2 Years of ICI or Achieved a Durable Response After Discontinuation Without Disease Progression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Outcomes in Patients With Advanced and/or Metastatic Non-Small Cell Lung Cancer who Completed 2 Years of Immune Checkpoint Inhibitors or Achieved a Durable Response After Discontinuation Without Disease Progression: Multicenter, Real-World Data (KCSG LU20-11)
Cancer 2021 Oct 27;[EPub Ahead of Print], H Kim, DW Kim, M Kim, Y Lee, HK Ahn, JH Cho, IH Kim, YG Lee, SH Shin, SE Park, J Jung, EJ Kang, MJ AhnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.